In 2023 Danish biotech startup 21st.BIO opened a 12,000-square-foot R&D facility in Davis, its first U.S. location. Founded in 2020, 21st.BIO is a technology and service partner for precision fermentation companies. The company builds state-of-the-art microbial cell factory and production processes and helps their customers to transition quickly and efficiently from molecule innovation to cost-effective large-scale production. 21st.BIO’s technology is in part licensed from Novozymes, which has developed the technology over several decades and has used it for manufacturing multiple enzyme products for food and industrial applications.
—
Learn more
View our Success Story series here to learn more about the advantages of doing business in Greater Sacramento and get additional insight into what’s driving the region’s economic momentum here.